Cargando…
Clinical specificity profile for novel rapid acting antidepressant drugs
Mood disorders are recurrent/chronic diseases with variable clinical remission rates. Available antidepressants are not effective in all patients and often show a relevant response latency, with a range of adverse events, including weight gain and sexual dysfunction. Novel rapid agents were develope...
Autores principales: | Scala, Mauro, Fanelli, Giuseppe, De Ronchi, Diana, Serretti, Alessandro, Fabbri, Chiara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams And Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373854/ https://www.ncbi.nlm.nih.gov/pubmed/37381161 http://dx.doi.org/10.1097/YIC.0000000000000488 |
Ejemplares similares
-
Pharmacogenetics of Antidepressants
por: Crisafulli, Concetta, et al.
Publicado: (2011) -
The dilemma of polypharmacy in psychosis: is it worth combining partial and full dopamine modulation?
por: Lippi, Matteo, et al.
Publicado: (2022) -
Pharmacogenetics of antidepressant response: An update
por: Drago, Antonio, et al.
Publicado: (2009) -
Clinical correlates and prognostic impact of binge-eating symptoms in major depressive disorder
por: Olgiati, Paolo, et al.
Publicado: (2022) -
Obsessive-Compulsive, Psychotic, and Autism Dimensions Overlap in Real World: A Case Report
por: Scala, Mauro, et al.
Publicado: (2023)